Loading...
NPI 1881632107 · Elgin, IL · Anatomic Pathology & Clinical Pathology Physician
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Gloria Ma is a anatomic pathology & clinical pathology physician provider located in Elgin, Illinois. This profile covers 27 Medicare and 155 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Individual |
| Organization | Gloria Ma |
| Address | 934 Center St |
| City | Elgin |
| State | IL |
| ZIP | 60120 |
| Taxonomy | Anatomic Pathology & Clinical Pathology Physician |
| NPI Enumerated | June 2, 2006 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $3.9M |
| Medicare | $87.6K |
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
27 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 88305 | The physician, typically a pathologist, performs a level IV examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 750 | $30 | $21.7K |
| 88341 | The lab analyst applies an additional single antibody stain on a slide or slides prepared from the same patient specimen as the initial antibody stain, such as tumor tissue. Then a qualified… | 600 | $20 | $13.2K |
| 88307 | The physician, typically a pathologist, performs a level V examination of a surgical pathology specimen. The examination includes accessioning the specimen into the lab, which involves formally… | 160 | $70 | $10.1K |
| 88342 | The lab analyst applies an initial single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 240 | $30 | $6.4K |
| 88360 | The lab analyst applies a single antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist, evaluates the… | 110 | $30 | $3.7K |
| 88173 | The lab analyst performs the technical lab test to analyze a cytopathology specimen from a fine needle aspirate and then interprets and reports the results. | 70 | $60 | $3.6K |
| 88312 | The lab analyst performs the technical lab steps to stain a specimen with a special stain. This code applies to Group I for microorganisms. A qualified provider, typically a pathologist, interprets… | 160 | $20 | $3.3K |
| 88112 | Selective cellular enhancement for cytopathology, such as the method of using a liquid–based slide preparation, uses a liquid–based medium to collect samples and preserve cells which can aid in… | 150 | $20 | $3.2K |
| 84165 | The lab analyst performs the technical lab test to separate and quantitate components of serum protein in a process called serum protein electrophoresis, SPE, or SPEP. The electrophoretic… | 270 | $10 | $3.2K |
| 88344 | The lab analyst applies a single multiplex antibody stain on a slide or slides prepared from a single patient specimen, such as tumor tissue. Then a qualified provider, typically a pathologist,… | 80 | $30 | $2.3K |
Showing 1–10 of 27
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 27 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
27 rows
| CPT/HCPCS Code | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|
| 88305 | 248 | 580 | 610 | $30 | $38.2K |
| 88341 | 45 | 450 | 210 | $30 | $11.9K |
| G0416 | 91 | 120 | 20 | $210 | $10.9K |
| 88342 | 100 | 490 | 120 | $40 | $9K |
| 88344 | 31 | 120 | 40 | $80 | $8.1K |
| 88360 | 60 | 260 | 60 | $60 | $7.7K |
| 88307 | 48 | 390 | 80 | $70 | $6.1K |
| 88312 | 46 | 310 | 40 | $50 | $5.7K |
| 88112 | 55 | 230 | 80 | $30 | $4.1K |
| 84165 | 33 | 130 | 110 | $10 | $4.1K |
Showing 1–10 of 27
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
155 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0241U | N/A | 5,970 | $80 | $447.9K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 6,610 | $60 | $390.2K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 67,190 | $10 | $336K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 87,510 | $1 | $262.5K |
| 87651 | The lab analyst performs a test for the bacteria Streptococcus, group A, using amplified nucleic acid probe technique. Strep A commonly causes acute pharyngitis, or strep throat. | 8,040 | $20 | $176.8K |
| 87880 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect Streptococcus, group A, in a patient sample, typically a throat swab. | 21,690 | $10 | $173.5K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 7,230 | $20 | $166.2K |
| 87804 | The analyst performs an immunoassay with direct optical, meaning visual, observation to detect influenza, also called flu, in a patient sample, typically a throat or nasal swab or nasal washings. | 8,870 | $10 | $106.4K |
| 80048 | The lab analyst performs a basic metabolic pane (BMP) test in which he measures the blood level of eight chemicals including total calcium, sodium, potassium, chloride, carbon dioxide, glucose, blood… | 24,920 | $1 | $99.7K |
| 83735 | The lab analyst performs a test to measure the amount of magnesium in a patient specimen. | 24,100 | $1 | $96.4K |
Showing 1–10 of 155
How this provider's Medicaid billing volume and revenue compare to other Illinois providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Illinois median
155 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 19 | 70 | 570 | $50 | $565.6K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 55 | 350 | 400 | $70 | $514.7K |
| 0240U | N/A | 6 | 20 | 240 | $120 | $403.4K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 45 | 280 | 1,120 | $30 | $218.9K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc,… | 100 | 210 | 680 | $20 | $206.4K |
| 87389 | The lab analyst performs a test to screen for human immunodeficiency virus, called HIV. The test screens for antigens of the HIV 1 virus and antibodies to the HIV 1 and HIV 2 viruses using an… | 152 | 250 | 450 | $40 | $185.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 56 | 360 | 600 | $30 | $165.1K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 58 | 360 | 630 | $30 | $165K |
| 87661 | The lab analyst performs a test for Trichomonas vaginalis using nucleic acid amplified probe technique. | 49 | 160 | 300 | $20 | $145.2K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 21 | 110 | 200 | $40 | $111.1K |
Showing 1–10 of 155
Other providers in the same ZIP code as Gloria Ma, ranked by combined Medicare and Medicaid revenue.
| Provider | State | Taxonomy | Medicare Revenue | Medicaid Revenue |
|---|---|---|---|---|
| Greater Family Health | IL | Federally Qualified Health Center (FQHC) | $0 | $82M |
| City Of Elgin | IL | Land Ambulance | $873K | $34.5M |
| Vna Health Care | IL | Federally Qualified Health Center (FQHC) | $0 | $18.5M |
| Greater Family Health | IL | Federally Qualified Health Center (FQHC) | $0 | $10.8M |
| Rapid Healthcare Laboratory LLC | IL | Clinical Medical Laboratory | $2.4M | $7.4M |
| School District U46 | IL | Local Education Agency (LEA) | $0 | $6.5M |
| Amjad Mahairi | IL | Dentist | $0 | $4.6M |
| Maurice Binns | IL | Emergency Medicine Physician | $65.5K | $522.5K |
| Alex Sanchez | IL | Geriatric Medicine (Internal Medicine) Physician | $361.7K | $182.9K |
| Heena Shyamani | IL | Internal Medicine Physician | $313.3K | $59.6K |
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.